3.1 - BD MAX™ System The new BD MAX™ is the first fully-automated benchtop molecular system for both CE-IVD and user-defined protocols allowing to run multiple specimen types and assays simultaneously. IMAGINE the possibilities...
The BD MAX™ platform is an open system which enables laboratories to program and automate user-defined thermocycling and PCR-analysis protocols. Laboratories can use user-defined assays and other commercial assays in addition to those developed by BD.
All the reagents necessary for cell lysis, nucleic acid extraction, amplification and detection are contained in unitized reagent strips: pipette tips, lytic enzymes, extraction reagents, magnetic beads, wash buffers, master mix, probes, primers and internal control.
Amplification takes place in micro-fluidic PCR cartridges consisting of 24 reaction chambers
To receive more information, please contact BD at: BDMAX@europe.bd.com EXPLORE the possibilities... IVD Molecular Diagnostic Testing
BD is building a broad content-rich menu of molecular diagnostics assays on the BD MAX™ enabling laboratories to deliver critical information to caregivers faster and more efficiently than currently available methods.
BD MAX™ MRSA Assay is validated to rapidly and accurately identify methicillin-resistant Staphylococcus aureus (MRSA) in patients, enabling rapid infection control measures that can positively impact patient management.
BD MAX™ Cdiff Assay: this diagnostic test is intended to rapidly, and accurately identify patients with clostridium difficile Infection(CDI) enabling appropriate treatment and infection control measures to be implemented quickly, helping to improve patient outcomes. The assay is designed to detect the toxin B gene (tcdB), the gene present in toxigenic C. difficile.
As the rate of C. diff infections continues to increase in hospitals and healthcare facilities worldwide, rapid, molecular testing for detection of toxigenic C.diff can help expedite appropriate treatment, reduce length of stay, and improve patient outcomes. 1,2
BD MAX™ StaphSR Assay delivers accurate and timely detection of MRSA & SA and is a key contributor to health intervention programs to prevent surgical site infections (SSIs) in healthcare settings. The StaphSR Assay with eXTended Detection Technology accurately identifies MRSA strains with the novel mecC cassette and new MREJ types and also the mecA dropouts that can cause MRSA false positives. Simple & Efficient Workflow with less than 1 minute of hands-on time per specimen and results in about 2 hours. StaphSR testing can be combined with other HAI assays (MRSA, Cdiff and CRE RUO) and IVD assays from different syndromes (Enteric Bacterial).
User-defined protocols cannot be performed in the same run as IVD/CE assays.
1. Aberra et al., Medscape: Clostridium Difficile Colitis Epidemiology 2012; http://emedicine.medscape.com/article/186458-overview, To receive more information, please contact BD at: BDMAX@europe.bd.com | ||||||||||||||||
| ||||||||||||||||
3.2 - BD GeneOhm™ CDiff
The Answer You Need Today From a Single Test Result Assay Features
Clinical Advantages
| ||||||||||||||||
| ||||||||||||||||
3.3 - BD GeneOhm™ StaphSR
Assay Features:
Clinical Advantages:
| ||||||||||||||||
| ||||||||||||||||
3.4 - BD BACTEC™ FX
The BACTEC™ FX blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections | ||||||||||||||||
| ||||||||||||||||
3.5 - BD Phoenix™
The BD Phoenix™ Automated Microbiology System , with its unique technology for susceptibility testing, provides high accuracy combined with rapid time to result. Because MRSA, VRE and Extended Spectrum beta-lactamase (ESBL) are the most important resistance markers linked to HAIs, the performance of the laboratory’s ID-AST system to detect these mechanisms is critical.
|